Ultrastructural morphology exhibited by coronaviruses.
CDC/ Alissa Eckert, MS; Dan Higgins, MAM
Since November 2019, the novel coronavirus known as SARS-CoV-2 (formerly, 2019-nCoV) has devastated communities and overwhelmed healthcare facilities worldwide. Research on the virus, its epidemiology, modes of infection, and potential treatments has been rapid, providing new insights to guide both clinical practice and public health recommendations each day.
The ability to share discoveries quickly is at the heart of the preprint mission, and facilitating it has been central to the ethos of Research Square since its founding. At no time is this goal more salient or pressing than in times of public health emergencies. Here, we aim to provide the most recent Research Square preprints relevant to the COVID-19 outbreak and its wide-ranging effects on the global community. All content posted here is free to read and download, and we encourage readers to engage via comments and annotations.
Polarised human alveolar epithelia enable identification of dichloroacetate as an effective drug against respiratory viruses
Short-term exposure to ambient air pollution and mortality and hospital admission in the Netherlands
Creutzfeldt-Jakob Disease with Initial Typical Parkinsonism Precipitated by COVID-19? A Case Report
The association between loneliness and mental health disorders in older people after the COVID-19 pandemic
The role of vitamin D as a preventive strategy in COVID-19 infections: evidence from South Asia
Determination of COVID-19 intensive care costs in Germany and assessment of the economic impact on the healthcare system - a nationwide retrospective cohort study from January 2020 to March 2022
The impact of weather on the spread of COVID-19. The case of the two largest cities in Greece
Cold case: COVID-19-triggered type 1 cryoglobulinemia
Racial/Ethnic Differences in Long-COVID-Associated Symptoms among Pediatrics Population: Findings from Difference-in-differences Analyses in RECOVER Program
New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides